Moleculin Biotech faces critical funding test as Annamycin’s 43% leukemia remission rate advances toward pivotal readout
PulseAI wins FDA clearance for smartwatch ECG analysis after study shows 92% fewer inconclusive results
Read More Pharma Industry News Janssen Pharmaceutical’s IMBRUVICA and Rituximab combo wins FDA approval for waldenström’s macroglobulinemia treatment Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has received approval from the US Food and Drug Administration… bypharmanewsdailyAugust 27, 2018
